Skip to main page content
HOME
CURRENT ISSUE
ARCHIVE
FEEDBACK
SUBSCRIPTIONS
ALERTS
HELP
Keywords
GO
Advanced »
Institution: Stanford Univ Med Ctr Lane Med Lib/Periodical Dept/Rm L109
Sign In as Member / Individual
User Name
Password
Sign In
Rare Diseases, Orphan Drugs, and Orphaned Patients
Table 1.
Numbers of Orphan Drugs Approved by the FDA for Orphan Diseases
Disease
Number Approved
Data adapted from Haffner, M.
N. Engl. J. Med.
©2006
Cancers
38
Metabolic Diseases
37
Infectious Diseases
23
Neurological Diseases
18
Hematological Diseases
16
Pulmonary Diseases
9
Poisonings
9
This Article
MI
August 2006
vol. 6
no. 4
186-191
Full Text
Full Text (PDF)
Current Issue
April 2011, 11 (2)
Alert me to new issues of MI
Instructions to Authors
About Molecular Interventions
Editorial Board
Subscription Information
Advertising
Terms, Conditions & Permissions Requests
RSS Feeds
Customized Alerts
All ASPET Journals
Molecular Pharmacology
Drug Metabolism and Disposition
J Pharmacology and Experimental Therapeutics
Pharmacological Reviews